Suppr超能文献

接种 Medigen 疫苗生物制品公司的 COVID-19 疫苗后出现多发性一过性白点综合征。

Multiple Evanescent White Dot Syndrome Following Medigen Vaccine Biologics Corporation COVID-19 Vaccination.

机构信息

Ophthalmology Department, Taipei City Hospital, Taipei, Taiwan.

出版信息

Ocul Immunol Inflamm. 2022 Jul;30(5):1278-1281. doi: 10.1080/09273948.2022.2062388. Epub 2022 Apr 20.

Abstract

PURPOSE

To report a case of multiple evanescent white dot syndrome (MEWDS) following severe acute respiratory syndrome coronavirus 2 vaccination.

STUDY DESIGN

Case report.

RESULTS

A 36-year-old healthy Taiwanese female was presented with flashing lights in the right eye two days after the first dose of Medigen Vaccine Biologics Corporation (MVC) coronavirus disease 19 (COVID-19) vaccine. Examination of the retina revealed multiple white dots in the posterior pole extending to the mid-periphery. Disruption of ellipsoid zone on optical coherence tomography, early hyperfluorescence on fluorescein angiography, late hypo-cyanescence on indocyanine green angiography, and paracentral scotoma on visual field test were consistent with MEWDS. At four-week follow-up, the patient's fundus lesions resolved, and symptoms subsided without treatment.

CONCLUSION

Resembling previous post-vaccine MEWDs cases, the symptoms are self-limited, and the visual prognosis is excellent. The presented case demonstrates MEWDS following MVC COVID-19 vaccine and suggests the immune-mediated basis for MEWDS in predisposed patients.

摘要

目的

报告一例接种严重急性呼吸综合征冠状病毒 2 型疫苗后出现多发性一过性白点综合征(MEWDS)的病例。

研究设计

病例报告。

结果

一名 36 岁健康的中国台湾女性在接种美迪吉生物科技公司(MVC)新冠肺炎疫苗第一剂后两天出现右眼闪光。眼底检查发现后极部至中周部有多个白色斑点。光相干断层扫描显示椭圆体带中断,荧光素血管造影早期呈强荧光,吲哚青绿血管造影晚期呈低荧光,视野检查呈旁中心暗点,均符合 MEWDS 表现。四周随访时,患者眼底病变消退,症状自行缓解,无需治疗。

结论

与既往疫苗接种后 MEWDS 病例相似,症状为自限性,视力预后良好。本例提示 MVC 新冠肺炎疫苗接种后可能出现 MEWDS,并提示易感患者的 MEWDS 可能存在免疫介导机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验